In this study, we investigated the efficacy of targeted drug delivery of an inhibitory biopolymer (Bac-ELP1-H1) in conjunction with systemic chemotherapy (TMZ) in the suppression of tumor growth and enhancement of survival in a mouse glioblastoma model. The gene discussed is ELP1; the disease is glioblastoma.